Skip to main content

Table 2 Frequencies of hsa-miR-124 methylation detected by qMSP analysis

From: Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer

  methylation positivity (%) Combined (and/or) methylation positivity (%)
  hsa-miR-124-1 hsa-miR-124-2 hsa-miR-124-3 hsa-miR-124-1/-2/-3 hsa-miR-124-1/-2 hsa-miR-124-1/-3 hsa-miR-124-2/-3
Normal (n = 18) 0.0 0.0 5.6 5.6 0.0 5.6 5.6
CIN1 (n = 36) 27.8 5.6 11.1 30.6 30.6 27.8 13.9
CIN3 (n = 41) 46.3 19.5 9.8 58.5 58.5 48.8 26.8
SCC (n = 29) 86.2 82.8 72.4 93.1 93.1 89.7 86.2
AdCA (n = 15) 93.3 80.0 73.3 100.0 93.3 100.0 93.3
normal cytology without CIN (n = 22) 4.5 0.0 4.5 9.1 4.5 9.1 4.5
abnormal cytology with CIN3 (n = 21) 47.6 47.6 23.8 71.4 71.4 57.1 47.6